SEC Form 4 · accession 0001127602-18-009469
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 7:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | M | 20,072 | $59.41 | A | 324,012 | D | |
| Common Stock | Feb 28, 2018 | S | 10 | $107.065 | D | 324,002 | D | |
| Common Stock | Feb 28, 2018 | S | 500 | $107.10 | D | 323,502 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.12 | D | 323,402 | D | |
| Common Stock | Feb 28, 2018 | S | 20 | $107.195 | D | 323,382 | D | |
| Common Stock | Feb 28, 2018 | S | 40 | $107.22 | D | 323,342 | D | |
| Common Stock | Feb 28, 2018 | S | 10 | $107.235 | D | 323,332 | D | |
| Common Stock | Feb 28, 2018 | S | 309 | $107.24 | D | 323,023 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.29 | D | 322,923 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.305 | D | 322,823 | D | |
| Common Stock | Feb 28, 2018 | S | 10 | $107.365 | D | 322,813 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $107.39 | D | 322,613 | D | |
| Common Stock | Feb 28, 2018 | S | 110 | $107.40 | D | 322,503 | D | |
| Common Stock | Feb 28, 2018 | S | 153 | $107.405 | D | 322,350 | D | |
| Common Stock | Feb 28, 2018 | S | 70 | $107.445 | D | 322,280 | D | |
| Common Stock | Feb 28, 2018 | S | 30 | $107.45 | D | 322,250 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $107.50 | D | 322,050 | D | |
| Common Stock | Feb 28, 2018 | S | 506 | $107.505 | D | 321,544 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.51 | D | 321,444 | D | |
| Common Stock | Feb 28, 2018 | S | 194 | $107.52 | D | 321,250 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $107.58 | D | 321,050 | D | |
| Common Stock | Feb 28, 2018 | S | 210 | $107.585 | D | 320,840 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.59 | D | 320,740 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $107.605 | D | 320,640 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Feb 28, 2018 | M | 20,072 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 20,072 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.